FDA Inspection 932412 — Sinopharm Weiqida Pharmaceutical Co. Ltd.
The FDA completed an inspection of Sinopharm Weiqida Pharmaceutical Co. Ltd. on May 1, 2015 in Datong. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 1, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Datong (China)